MetaCap

Clene Statistics

NASDAQ: CLNNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.52+0.02 (+0.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Clene by the numbers

Clene has a market capitalization of $50.7 million based on 14.40M shares outstanding. With trailing EPS of $-2.30, Clene is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.1% below its 50-day average and 31.2% below its 200-day average.

Average daily trading volume is 115.06K shares, or about $405,008 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CLNN valuation vs. peer median

CLNN compared with the median of 8 peer companies
MetricCLNNPeer medianDifference
Market cap$50.69M$50.02M+1%
Avg. volume115.06K208.27K-45%

Peer median across 8 companies: ALDX, ACRV, LFVN, XBIT, HRTX, RFL, ONCY, CTOR.

Valuation

Market cap
$50.69M
Price / sales (latest FY)
253.44
EPS (TTM)
$-2.30

Price and trading

Previous close
3.50
Open
3.41
Day range
3.30 – 3.60
52-week range
3.02 – 10.84
52-week change
-62.03%
Beta
—
Volume
143.56K

Dividends and events

Annual dividend
None
Next earnings date
Aug 13, 2025

Additional statistics

Market Cap
50.69M
Forward Pe
-1.44
Eps
-2.30
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
10.84
Week52 Low
3.02
Avg Volume
115.06K
Shares Outstanding
14.40M
Ma50
3.87
Ma200
5.12
Earnings Date
Aug 13, 2025
Pct From52w High
-67.53%
Pct From52w Low
16.56%

Related